The anatomy of first-episode and chronic schizophrenia: An anatomical likelihood estimation meta-analysis

American Journal of Psychiatry

Volumn 165, Issue 8, 2008, Pages 1015-1023

  Ellison Wright, Ian ^a   Glahn, David C ^b   Laird, Angela R ^b   Thelen, Sarah M ^b   Bullmore, Ed ^b  

^a AVON AND WILTSHIRE MENTAL HEALTH PARTNERSHIP NHS TRUST   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYGDALOID NUCLEUS; ANATOMICAL LIKELIHOOD ESTIMATION; ARTICLE; BASAL GANGLION; BRAIN CORTEX; BRAIN MAPPING; BRAIN REGION; BRAIN SIZE; CAUDATE NUCLEUS; CINGULATE GYRUS; DISEASE COURSE; FEMALE; GRAY MATTER; HUMAN; INSULA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHIZOPHRENIA; STATISTICAL MODEL; THALAMOCORTICAL TRACT; THALAMUS;

BRAIN; CHRONIC DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; SCHIZOPHRENIA; TIME FACTORS;

EID: 48949087605     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.2008.07101562     Document Type: Article

References (72)

1. Steen RG, Mull C, McClure R, Hamer RM, Lieberman JA: Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry 2006; 188:510-518
2. Vita A, De Peri L, Silenzi C, Dieci M: Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res 2006; 82:75-88
3. Vita A, de Peri L: Hippocampal and amygdala volume reductions in first-episode schizophrenia. Br J Psychiatry 2007; 190:271
4. Lawrie SM, Abukmeil SS: Brain abnormality in schizophrenia: a systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry 1998; 172:110-120
5. Wright IC, Rabe-Hesketh S, Woodruff PWR, David AS, Murray RM, Bullmore ET: Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 2000; 157:16-25
6. Shenton ME, Dickey CC, Frumin M, McCarley RW: A review of MRI findings in schizophrenia. Schizophr Res 2001; 49:1-52
7. Borgwardt SJ, Riecher-Rossler A, Dazzan P, Chitnis X, Aston J, Drewe M, Gschwandtner U, Haller S, Pfluger M, Rechsteiner E, D'Souza M, Stieglitz RD, Radu EW, McGuire PK: Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry 2007; 61:1148-1156
8. Job DE, Whalley HC, Johnstone EC, Lawrie SM: Grey matter changes over time in high risk subjects developing schizophrenia. Neuroimage 2005; 25:1023-1030
9. Killackey E, Yung AR: Effectiveness of early intervention in psychosis. Curr Opin Psychiatry 2007; 20:121-125
10. Buckley PE, Evans D: First-episode schizophrenia: a window of opportunity for optimizing care and outcomes. Postgrad Med 2006; spec no:5-19
11. Laird AR, Fox PM, Price CJ, Glahn DC, Uecker AM, Lancaster JL, Turkeltaub PE, Kochunov P, Fox PT: ALE meta-analysis: controlling the false discovery rate and performing statistical contrasts. Hum Brain Mapp 2005; 25:155-164
12. Turkeltaub PE, Eden GF, Jones KM, Zeffiro TA: Meta-analysis of the functional neuroanatomy of single-word reading: method and validation. Neuroimage 2002; 16:765-780
13. Chein JM, Fissell K, Jacobs S, Fiez JA: Functional heterogeneity within Broca's area during verbal working memory. Physiol Behav 2002; 77:635-639
14. Laird AR, McMillan KM, Lancaster JL, Kochunov P, Turkeltaub PE, Pardo JV, Fox PT: A comparison of label-based review and ALE meta-analysis in the Stroop task. Hum Brain Mapp 2005; 25:6-21
15. Wright IC, McGuire PK, Poline JB, Travere JM, Murray RM, Frith CD, Frackowiak RS, Friston KJ: A voxel-based method for the statistical analysis of gray and white matter density applied to schizophrenia. Neuroimage 1995; 2:244-252
16. Ashburner J, Friston KJ: Voxel-based morphometry: the methods. Neuroimage 2000; 11:805-821
17. Honea R, Crow TJ, Passingham D, Mackay CE: Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry 2005; 162:2233-2245
18. Ananth H, Popescu I, Critchley HD, Good CD, Frackowiak RSJ, Dolan RJ: Cortical and subcortical gray matter abnormalities in schizophrenia determined through structural magnetic resonance imaging with optimized volumetric voxel-based morphometry. Am J Psychiatry 2002; 159:1497-1505
19. Antonova E, Kumari V, Morris R, Halari R, Anilkumar A, Mehrotra R, Sharma T: The relationship of structural alterations to cognitive deficits in schizophrenia: a voxel-based morphometry study. Biol Psychiatry 2005; 58:457-467
20. Bassitt DP, Neto MR, de Castro CC, Busatto GF: Insight and regional brain volumes in schizophrenia. Eur Arch Psychiatry Clin Neurosci 2007; 257:58-62
21. Chua SE, Cheung C, Cheung V, Tsang JT, Chen EY, Wong JC, Cheung JP, Yip L, Tai KS, Suckling J, McAlonan GM: Cerebral grey, white matter and CSF in never-medicated, first-episode schizophrenia. Schizophr Res 2007; 89:12-21
22. Giuliani NR, Calhoun VD, Pearlson GD, Francis A, Buchanan RW: Voxel-based morphometry versus region of interest: a comparison of two methods for analyzing gray matter differences in schizophrenia. Schizophr Res 2005; 74:135-147
23. Ha TH, Youn T, Ha KS, Rho KS, Lee JM, Kim IY, Kim SI, Kwon JS: Gray matter abnormalities in paranoid schizophrenia and their clinical correlations. Psychiatry Res 2004; 132:251-260
24. Hulshoff Pol HE, Schnack HG, Mandl RC, van Haren NE, Koning H, Collins DL, Evans AC, Kahn RS: Focal gray matter density changes in schizophrenia. Arch Gen Psychiatry 2001; 58:1118-1125
25. Jayakumar PN, Venkatasubramanian G, Gangadhar BN, Janakiramaiah N, Keshavan MS: Optimized voxel-based morphometry of gray matter volume in first-episode, antipsychotic-naive schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29:587-591
26. Job DE, Whalley HC, McConnell S, Glabus M, Johnstone EC, Lawrie SM: Structural gray matter differences between first-episode schizophrenics and normal controls using voxel-based morphometry. Neuroimage 2002; 17:880-889
27. Kasparek T, Prikryl R, Mikl M, Schwarz D, Ceskova E, Krupa P: Prefrontal but not temporal grey matter changes in males with first-episode schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:151-157
28. Kawasaki Y, Suzuki M, Kherif F, Takahashi T, Zhou SY, Nakamura K, Matsui M, Sumiyoshi T, Seto H, Kurachi M: Multivariate voxel-based morphometry successfully differentiates schizophrenia patients from healthy controls. Neuroimage 2007; 34:235-242
29. Kubicki M, Shenton ME, Salisbury DF, Hirayasu Y, Kasai K, Kikinis R, Jolesz FA, McCarley RW: Voxel-based morphometric analysis of gray matter in first episode schizophrenia. Neuroimage 2002; 17:1711-1719
30. Marcelis M, Suckling J, Woodruff P, Hofman P, Bullmore E, van Os J: Searching for a structural endophenotype in psychosis using computational morphometry. Psychiatry Res 2003; 122:153-167
31. McIntosh AM, Job DE, Moorhead TW, Harrison LK, Forrester K, Lawrie SM, Johnstone EC: Voxel-based morphometry of patients with schizophrenia or bipolar disorder and their unaffected relatives. Biol Psychiatry 2004; 56:544-552
32. Moorhead TW, Job DE, Whalley HC, Sanderson TL, Johnstone EC, Lawrie SM: Voxel-based morphometry of comorbid schizophrenia and learning disability: analyses in normalized and native spaces using parametric and nonparametric statistical methods. Neuroimage 2004; 22:188-202
33. Neckelmann G, Specht K, Lund A, Ersland L, Smievoll AI, Neckelmann D, Hugdahl K: MR morphometry analysis of grey matter volume reduction in schizophrenia: association with hallucinations. Int J Neurosci 2006; 116:9-23
34. Ohnishi T, Hashimoto R, Mori T, Nemoto K, Moriguchi Y, Iida H, Noguchi H, Nakabayashi T, Hori H, Ohmori M, Tsukue R, Anami K, Hirabayashi N, Harada S, Arima K, Saitoh O, Kunugi H: The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Brain 2006; 129:399-410
35. Paillere-Martinot M, Caclin A, Artiges E, Poline JB, Joliot M, Mallet L, Recasens C, Attar-Levy D, Martinot JL: Cerebral gray and white matter reductions and clinical correlates in patients with early onset schizophrenia. Schizophr Res 2001; 50:19-26
36. Salgado-Pineda P, Junque C, Vendrell P, Baeza I, Bargallo N, Falcon C, Bernardo M: Decreased cerebral activation during CPT performance: structural and functional deficits in schizophrenic patients. Neuroimage 2004; 21:840-847
37. Salgado-Pineda P, Baeza I, Perez-Gomez M, Vendrell P, Junque C, Bargallo N, Bernardo M: Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients. Neuroimage 2003; 19:365-375
38. Shapleske J, Rossell SL, Chitnis XA, Suckling J, Simmons A, Bullmore ET, Woodruff PW, David AS: A computational morphometric MRI study of schizophrenia: effects of hallucinations. Cereb Cortex 2002; 12:1331-1341
39. Sigmundsson T, Suckling J, Maier M, Williams SCR, Bullmore ET, Greenwood KE, Fukuda R, Ron MA, Toone BK: Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms. Am J Psychiatry 2001; 158:234-243
40. Suzuki M, Nohara S, Hagino H, Kurokawa K, Yotsutsuji T, Kawasaki Y, Takahashi T, Matsui M, Watanabe N, Seto H, Kurachi M: Regional changes in brain gray and white matter in patients with schizophrenia demonstrated with voxel-based analysis of MRI. Schizophr Res 2002; 55:41-54
41. Whitford TJ, Grieve SM, Farrow TF, Gomes L, Brennan J, Harris AW, Gordon E, Williams LM: Progressive grey matter atrophy over the first 2-3 years of illness in first-episode schizophrenia: a tensor-based morphometry study. Neuroimage 2006; 32:511-519
42. Wilke M, Kaufmann C, Grabner A, Putz B, Wetter TC, Auer DP: Gray matter changes and correlates of disease severity in schizophrenia: a statistical parametric mapping study. Neuroimage 2001; 13:814-824
43. Wright IC, Ellison ZR, Sharma T, Friston KJ, Murray RM, McGuire PK: Mapping of grey matter changes in schizophrenia. Schizophr Res 1999; 35:1-14
44. Yamada M, Hirao K, Namiki C, Hanakawa T, Fukuyama H, Hayashi T, Murai T: Social cognition and frontal lobe pathology in schizophrenia: a voxel-based morphometric study. Neuroimage 2007; 35:292-298
45. Whitford TJ, Farrow TF, Gomes L, Brennan J, Harris AW, Williams LM: Grey matter deficits and symptom profile in first episode schizophrenia. Psychiatry Res 2005; 139:229-238
46. Kawasaki Y, Suzuki M, Nohara S, Hagino H, Takahashi T, Matsui M, Yamashita I, Chitnis XA, McGuire PK, Seto H, Kurachi M: Structural brain differences in patients with schizophrenia and schizotypal disorder demonstrated by voxel-based morphometry. Eur Arch Psychiatry Clin Neurosci 2004; 254:406-414
47. Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L, Kochunov PV, Nickerson D, Mikiten SA, Fox PT: Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 2000; 10:120-131
48. Talairach J, Tournoux P: Co-Planar Stereotaxic Atlas of the Human Brain: Three-Dimensional Proportional System. New York, Thieme Medical, 1988
49. Rorden C, Karnath HO, Bonilha L: Improving lesion-symptom mapping. J Cogn Neurosci 2007; 19:1081-1088
50. Fox PT, Laird AR, Lancaster JL: Co-ordinate-based voxel-wise meta-analysis: dividends of spatial normalization: report of a virtual workshop. Hum Brain Mapp 2005; 25:1-5
51. Konick LC, Friedman L: Meta-analysis of thalamic size in schizophrenia. Biol Psychiatry 2001; 49:28-38
52. Baiano M, David A, Versace A, Churchill R, Balestrieri M, Brambilla P: Anterior cingulate volumes in schizophrenia: a systematic review and a meta-analysis of MRI studies. Schizophr Res 2007; 93:1-12
53. Nelson MD, Saykin AJ, Flashman LA, Riordan HJ: Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry 1998; 55:433-440
54. Crespo-Facorro B, Roiz-Santianez R, Pelayo-Teran JM, Gonzalez-Blanch C, Perez-Iglesias R, Gutierrez A, de Lucas EM, Tordesillas D, Vazquez-Barquero JL: Caudate nucleus volume and its clinical and cognitive correlations in first episode schizophrenia. Schizophr Res 2007; 91:87-96
55. Lang DJ, Khorram B, Goghari VM, Kopala LC, Vandorpe RA, Rui Q, Smith GN, Honer WG: Reduced anterior internal capsule and thalamic volumes in first-episode psychosis. Schizophr Res 2006; 87:89-99
56. Ettinger U, Picchioni M, Landau S, Matsumoto K, van Haren NE, Marshall N, Hall MH, Schulze K, Toulopoulou T, Davies N, Ribchester T, McGuire PK, Murray RM: Magnetic resonance imaging of the thalamus and adhesio interthalamica in twins with schizophrenia. Arch Gen Psychiatry 2007; 64:401-409
57. Preuss UW, Zetzsche T, Jäger M, Groll C, Frodl T, Bottlender R, Leinsinger G, Hegerl U, Hahn K, Müller HJ, Meisenzahl EM: Thalamic volume in first-episode and chronic schizophrenic subjects: a volumetric MRI study. Schizophr Res 2005; 73:91-101
58. Fornito A, Yücel M, Wood SJ, Adamson C, Velakoulis D, Saling MM, McGorry PD, Pantelis C: Surface-based morphometry of the anterior cingulate cortex in first episode schizophrenia. Hum Brain Mapp (Epub May 24, 2007)
59. Gray's Anatomy: The Anatomical Basis of Medicine and Surgery, 38th ed. Edited by Williams P. New York, Churchill Livingstone, 1995, pp 1186-1200
60. Camchong J, Dyckman KA, Chapman CE, Yanasak NE, McDowell JE: Basal ganglia-thalamocortical circuitry disruptions in schizophrenia during delayed response tasks. Biol Psychiatry 2006; 60:235-241
61. Keshavan MS, Rosenberg D, Sweeney JA, Pettegrew JW: Decreased caudate volume in neuroleptic-naive psychotic patients. Am J Psychiatry 1998; 155:774-778
62. Lang DJ, Kopala LC, Vandorpe RA, Rui Q, Smith GN, Goghari VM, Honer WG: An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone. Am J Psychiatry 2001; 158:625-631
63. Glenthoj A, Glenthoj BY, Mackeprang T, Pagsberg AK, Hemmingsen RP, Jernigan TL, Baare WF: Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug. Psychiatry Res 2007; 154:199-208
64. Rajarethinam R, Upadhyaya A, Tsou P, Upadhyaya M, Keshavan MS: Caudate volume in offspring of patients with schizophrenia. Br J Psychiatry 2007; 191:258-259
65. Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AI, Gur RE, McEvoy J, Perkins D, Hamer RM, Gu H, Tohen M; HGDH Study Group: Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 2005; 62:361-370
66. Deshmukh A, Rosenbloom MJ, De Rosa E, Sullivan EV, Pfefferbaum A: Regional striatal volume abnormalities in schizophrenia: effects of comorbidity for alcoholism, recency of alcoholic drinking, and antipsychotic medication type. Schizophr Res 2005; 79:189-200
67. Scherk H, Falkai P: Effects of antipsychotics on brain structure. Curr Opin Psychiatry 2006; 19:145-150
68. Gur RE, Maany V, Mozley PD, Swanson C, Bilker W, Gur RC: Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am J Psychiatry 1998; 155:1711-1717
69. Dazzan P, Morgan KD, Orr K, Hutchinson G, Chitnis X, Suckling J, Fearon P, McGuire PK, Mallett RM, Jones PB, Leff J, Murray RM: Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology 2005; 30:765-774
70. Job DE, Whalley HC, McIntosh AM, Owens DG, Johnstone EC, Lawrie SM: Grey matter changes can improve the prediction of schizophrenia in subjects at high risk. BMC Med 2006; 4:29
71. Davatzikos C, Shen D, Gur RC, Wu X, Liu D, Fan Y, Hughett P, Turetsky BI, Gur RE: Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities. Arch Gen Psychiatry 2005; 62:1218-1227
72. Mamah D, Wang L, Barch D, de Erausquin GA, Gado M, Csernansky JG: Structural analysis of the basal ganglia in schizophrenia. Schizophr Res 2007; 89:59-71